Idera Pharmaceuticals, Inc. Provides Update on Drug Candidate Pipeline Targeted to Toll-like Receptors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today provided an update on its drug candidate pipeline targeted to Toll-like Receptors (TLRs) during its 2009 Annual Meeting of Stockholders.